China Pharma Holdings Inc Risk Assessment: Volatility and Market Trends
China Pharma Holdings Inc (CPHI) has been assessed for risk by TradingKey, with a score of 2.42 out of 155 in the Pharmaceuticals industry.
The U.S. Dollar Index is currently neutral, having a neutral effect on the domestic-focused industry.
According to the assessment, CPHI's beta value is 1.12, indicating that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.